Buyang Huanwu Decoction(BYHWD),a commonly used formula for treating"Qi deficiency and blood stasis"syndrome,is widely used in modern clinical medicine to prevent or treat ischemic cardia-cerebrovascular and thromboembolic diseases,etc.Therefore,this article aims to summarize the clinical research progress and related mechanisms of BYHWD in treating thrombosis,so as to provide supporting evidence and basis for its clinical application in thrombotic diseases.This article reviewed the research findings from the past fifteen years on the anti-thrombotic properties of BYHWD.It also discussed the strengths and weaknesses of BYWHD in the treatment of thrombotic diseases,offering insights into potential areas for future research.BYHWD can effectively alleviate thrombotic diseases by improving hemorheology parameters,reducing platelet function,protecting endothelial function,promoting fibrinolysis activity,and exerting anti-inflammatory effects.BYHWD can prevent and treat thrombotic diseases through multiple targets and multiple levels,making it a promising option for clinical applications.

Ginsenoside Compound K(CK)is a kind of protopanaxadiol ginsenosides,which exerts antitumor effects on various cancers,such as lung cancer,liver cancer and breast cancer.Pharmacological studies have proved that CK induces tumor cell cycle arrest and apoptosis,as well as regulates tumor cell autophagy and inhibits tumor metastasis by regulating multiple signaling pathways(AMPK/mTOR and PI3K/Akt et cetera).However,as an intestinal metabolite of natural protopanaxadiol ginsenosides,CK cannot be directly extracted from the ginseng plant.Therefore,biotransformation from natural ginsenosides such as ginsenoside Rb1 or biosynthesis are utilized to obtain CK.Biotransformation of CK uses enzymes or microorganisms to transform different ginsenosides or their structural analogs into CK;biosynthesis of CK cultures cell factories and biosynthetic enzymes to synthesize glucose and other simple compounds into CK.In this review,we systematically summarized the research progress in biopreparation and antitumor mechanism of CK in recent years,with the aim of providing evidence for the future development of CK as a clinical anti-tumor candidate drug or an adjunctive drug.